Antimyeloperoxidase antibodies modulate inflammatory responses and activate profibrotic pathways in human monocytes. (2023)
Attributed to:
MICA: Myeloperoxidase inhibition as a potential therapy in anti-neutrophil cytoplasmic antibody vasculitis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jaut.2023.103060
PubMed Identifier: 37331172
Publication URI: http://europepmc.org/abstract/MED/37331172
Type: Journal Article/Review
Volume: 139
Parent Publication: Journal of autoimmunity
ISSN: 0896-8411